アラクス健康プラス　サラシア: notification withdrawn

アラクス健康プラス　サラシア: notification withdrawn : Food with function claims notified in Japan. This notification does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

CAA, Japan Foods with Function Claims notifications, retrieved 27 October 2026.

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約第1.0版), compatible CC BY 4.0

Registration number: A275
Type: Processed food (tablets, capsules and similar forms)
Published status: Notification withdrawn
Notifier: 株式会社アラクス
Notification date: 2016-03-17
Modification date: 2019-08-20
Withdrawal date: 2024-10-04

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Information
A claim declared in Japan is not an authorised health claim in the European Union.
CAA, Japan Foods with Function Claims notifications, retrieved 27 October 2026.
Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.
Public Data License 1.0 (公共データ利用規約第1.0版), compatible CC BY 4.0

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredient	Published text and quantity	Identified nutrient or substance
サラシア由来サラシノール	サラシア由来サラシノール : 0.6mg (par jour)	Not identified

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

サラシア含有加工食品

Declared claim (original Japanese text)

本品にはサラシア由来サラシノールが含まれます。サラシア由来サラシノールには食後血糖値の上昇を抑える機能があることが報告されています。

Precautions (original Japanese text)

糖尿病薬との併用はおやめください。1日の摂取目安量を守ってください。

Reason for withdrawal (original Japanese text)

販売予定がないため

Raw materials of functional ingredients (original Japanese text)

サラシアエキス末

Recommended daily intake (original Japanese text)

3粒

Method of consumption (original Japanese text)

食事前に1粒ずつ、水などと一緒にお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

サラシア由来サラシノール

Declared daily quantities (original Japanese text)

0.6mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

View published fields and their variants

Functional component amount: 0.6mg
Functional component: サラシア由来サラシノール
Published daily intake: 3粒
Published designation: サラシア含有加工食品
Product name: アラクス健康プラス　サラシア
Published last update: 2019/08/20
Reason for withdrawal: 販売予定がないため
Publication date: 2016/03/17
Notification number: A275
Published intake method: 食事前に1粒ずつ、水などと一緒にお召し上がりください。
Published precautions: 糖尿病薬との併用はおやめください。1日の摂取目安量を守ってください。
Declared withdrawal: 1
Withdrawal date: 2024/10/04
Official scientific dossier: https://www.fld.caa.go.jp/caaks/s/cssc01/fwccd01?c__id=a09F900004sk8MEIAY
Functional component: サラシア由来サラシノール
Company: 株式会社アラクス
Claimed function in the source: 本品にはサラシア由来サラシノールが含まれます。サラシア由来サラシノールには食後血糖値の上昇を抑える機能があることが報告されています。
Product category: 加工食品(錠剤、カプセル剤等)
Published marketing status: 販売休止中
Functional component raw materials: サラシアエキス末

Official source

View the official register, number A275